Guzel, AhmetBiner, Betul OrhanerKarasalihoglu, SerapAylanc, Hakan2024-06-122024-06-1220112146-31232146-3131https://doi.org/10.5174/tutfd.2009.02192.0https://hdl.handle.net/20.500.14551/23630Diclofenac, a widely used nonsteroidal anti-inflammatory drug, has been reported to cause fatal drug-induced rhabdomyolysis very rarely. We report a case of a 13-month-old girl who developed fatal rhabdomyolysis after administration of intramuscular diclofenac for relief of pain caused by a scalding burn injury. Rhabdomyolysis due to diclofenac has not been reported in children. Here, we present the first case report to demonstrate rhabdomylysis secondary to diclofenac administration.en10.5174/tutfd.2009.02192.0info:eu-repo/semantics/openAccessRhabdomyolysisDiclofenacChildDrugSide EffectAirway CollapseTracheomalaciaTracheobronchomalaciaArticle281102106N/AWOS:0002930598000222-s2.0-79959682105Q3